Fas ligand (FasL) may play an important role in maintaining the immune privilege of intervertebral disc (IVD). Besides, it is closely related to the apoptosis of degenerative disc cells. Nowadays, lots of reports have described about the paradoxical effects of FasL, although the effect of FasL on IVD cells is still under debate. In this study, we tried to investigate the effects of FasL on Fas expression and on the apoptosis of nucleus pulposus (NP) cells in Sprague-Dawley rats. The results showed that the expression of Fas in NP cells was significantly increased by the recombinant FasL. Meanwhile, the apoptosis of NP cells increased markedly in a FasL dose-dependent manner. Interestingly, RNA interference results indicated that the increase of Fas expression and the NP cell apoptosis described previously were inhibited by Fas siRNA, suggesting that RNA interference might be one of novel strategies to prevent IVD cells from apoptosis.
Introduction
Intervertebral disc (IVD) degeneration is closely related to low back pain and spine-related disability. The process of IVD degeneration (IDD) is complicated interactions of various factors, such as aging, nutrition, trauma, abnormal mechanical stress, etc. [1] . The precise mechanism of IDD is still not fully understood. Recent findings on the existence of apoptosis cells in IVD have provided a new insight into the pathogenesis of IDD [2] . In degenerative disc tissues, increased cell apoptosis and high expressions of both Fas and Fas ligand (FasL) have been reported, which suggests that Fas and FasL are involved in the progression of IDD [3] [4] [5] [6] .
Fas/FasL system is a well-characterized apoptosis pathway [7] . Fas can be expressed in a wide variety of cell types, whereas FasL expression appears to be more restricted. FasL is a type II membrane protein of 36 kDa that belongs to the tumor necrosis factor (TNF) family, and upon binding to the Fas, it acts as a cell-death-triggering ligand to induce apoptosis [7, 8] . It has already been shown that FasL plays an important role in the preservation of the immune privilege of isolated issues by inducing Fas-mediated apoptosis of infiltrating inflammatory cells, such as the testes [9] , eyes [10] , and brain [11] . However, recent researches revealed that FasL was not only a well-characterized apoptosis inducer, but also a possible inflammatory agent [12] . Nevertheless, further investigations demonstrated that FasL could also induce some cells, including tumor cells [12] , osteoclast precursors [13] , and peritoneal exudate cells [14] , to secret inflammatory factors such as IL-1b, IL-18, TNF-a, etc., and directly up-regulate the expression of various chemokines [12, 15] . FasL has become an enigma molecule [12] .
It has recently been suggested that FasL played different roles in both normal and degenerative IVDs. Some reports have indicated that FasL played important roles in the formation and the immune privilege of the IVD [16, 17] , and the expression of FasL varied with aging [18, 19] . On the other hand, FasL was found to have a close relationship with IVD cell apoptosis [5] , and it was thought to contribute to disc degeneration [17] . Fas was also detected in the disc and the expression of Fas on IVD could be up-regulated by some factors such as trauma [17] and serum deprivation [6] . Our previous study also indicated that the Fas expression and the apoptosis of rat IVD cells might be affected by FasL in vitro [20] . But, the exact effect of FasL on IVD cells still has not been fully addressed.
Here, we tried to investigate the effects of FasL on Fas expression and on the apoptosis of IVD cells in Sprague-Dawley rat. And these effects were confirmed by the technique of RNA silence.
Materials and Methods
Animals and disc cell primary culture Male Sprague-Dawley rats (aged 3 months, weighing 396 + 45 g) obtained from the Experiment Animal Center of Sun Yat-Sen University (2007A0467, Guangzhou) were enrolled in the study. Experimental procedures were approved by the Animal Care and Use Committee of the Sun Yat-Sen University. Rats were euthanized by an overdose of pentobarbital (100 mg/kg body weight), and the lumbar IVDs were collected from the spinal column. The gel-like nucleus pulposus (NP) was separated from the annulus fibrosus, using a dissecting microscope under aseptic condition. The gelatinous NP tissues obtained from the same animal were pooled together and cut into small pieces (,1 mm 3 ) immediately in Dulbecco's modified Eagle's medium and Ham's F-12 medium (DMEM/F-12, Gibco, Gaithersburg, USA) with 10% fetal bovine serum (FBS, Hyclone, Logan, USA) and antibiotics (100 U/ml penicillin and 100 mg/ml streptomycin). To isolate the cells, the NP tissues were digested with 0.1% type II collagenase (Sigma, St Louis, USA) in DMEM/F-12 containing 10% FBS at 378C in a gyratory shaker (110 rpm) [20] . After 8 h, the suspension was filtered through a 70-mm mesh. The filtered cells were washed with DMEM/F-12 and then seeded in 25-cm 2 culture flasks. The cells were incubated in complete culture medium (DMEM/F-12 with 10% FBS and antibiotics) at 378C in a 5% CO 2 incubator. The medium was refreshed every 3 days. The rat NP cell is a kind of chondrocyte-like cell identified by toluidine blue and safranine dye staining, and collagen II histoimmunostaining. First-passage cells maintained in a monolayer were used throughout the experiments.
Normal NP cells treated with FasL
The primary NP cells were trypsinized and subcultured into 6-well plates at 3 Â 10 5 cells/well with complete culture medium at 378C in a 5% CO 2 incubator till the cells reached to 80-90% confluence. Then the medium was replaced with DMEM/F-12 containing 1% FBS without antibiotics for 12 h in order to synchronize the cells. The cells were then cultured with 0, 5, 10, 20, or 50 ng/ml recombinant rat FasL (R&D Systems, Minneapolis, USA), respectively, in refreshed DMEM/ F-12 containing 1% FBS without antibiotics for another 24 h. Cells cultured without FasL were used as a control. Then the cells were collected to extract total RNA and total protein to analyze the expression of Fas. The incidence of apoptosis was also detected by flow cytometry (FCM).
Reverse transcription -polymerase chain reaction Reverse transcription-polymerase chain reaction (RT-PCR) was performed to detect the expression of Fas gene. b-actin was used as the internal control. Briefly, total RNA was extracted from disc cells with Trizol reagent (Invitrogen, Carlsbad, USA) following the instructions. Single-strand cDNA templates were prepared from 2 mg total RNA using oligo(dT) 18 and Revert AidTM M-MuLV reverse transcriptase (Fermentas, Vilnius, Lithuania). Specific cDNAs were then amplified by PCR using the following primers (Sangon, Shanghai, 0 . PCR amplification from cDNA was performed in a final volume of 50 ml containing 15 mM MgCl 2 , 1.25 U Taq (Takara, Tokyo, Japan), and 0.3 mM specific primers, 0.1 nM each of dNTP (Takara). Cycling conditions were denaturing at 948C for 30 s, annealing (Fas 508C, b-actin 568C for 30 s), and elongating at 728C for 60 s; and the optimal cycle number was 35 cycles for Fas and 30 cycles for b-actin. All PCR products were subject to 2% agarose gel electrophoresis, aurosol staining, and visualization by ultraviolet transillumination. Gel images were then analyzed by densitometry using Scion Image (Scion Corporation, Frederick, USA). Fas gene expression data were presented as normalized to b-actin expression.
Western blot analysis
The expression of Fas protein was detected by western blot. b-actin expression was used as the internal control. Total protein was extracted from disc cells with RIPA buffer (Biyuntian Ltd, Nantong, China) according to the manufacturer's instructions. Protein concentration was determined by the BCA assay (Sigma). Protein extracts were electrophoresized in 5-12% Bis-Tris gel before transferring to PVDF membrane (0.45 mm). The membranes were blocked with 5% non-fat dry milk in TBST Effect of Fas ligand on intervertebral disc cells (50 mM Tris, pH 7.6, 150 mM NaCl, 0.1% Tween 20) for 1 h at 378C, and incubated overnight at 48C in 5% BSA in TBST with the anti-Fas antibody (48 kDa, Santa Cruz Biotechnology, Santa Cruz, USA) (1:1000) and anti-b-actin antibody (45 kDa, Cell Signaling Technology, Boston, USA) (1:1000), and finally incubated antiserum against rabbit IgG conjugated with horseradish peroxidase (Cell Signaling Technology) (1:1000) for 1 h. Membranes were treated with ECL Plus according to the manufacturer's instructions (Amersham Pharmacia Biotech, Umea, Sweden). Images were analyzed by densitometry from Scion Image. Fas protein expression data were presented as normalized to b-actin expression.
Flow cytometry
Apoptotic cells were counted by EpicsAltra (Beckman Coulter, Fullerton, USA) FCM stained with both annexin V-FITC and propidium iodide, according to the manufacturer's instructions. The morphology of NP cells was observed by phase-contrast microscopy. All the cells were collected and re-suspended in binding buffer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, and 2.5 mM CaCl 2 ) at a concentration of 1 Â 10 6 cells/ml. The cells were stained with 5 ml of annexin V-FITC and 5 ml of propidium iodide (Bender MedSystems, Vienna, Austria) for 15 min at room temperature in the dark, followed by addition of 400 ml of the binding buffer, and then analyzed by fluorescence-activated cell sorter within 1 h. Apoptotic cells, including those staining positive for annexin V-FITC and negative for propidium iodide and those double positive, were counted and represented as a percentage of the total cell count.
Small interference RNA and transfection Twenty-one-nucleotide duplex small interference RNA (siRNA) targeting rat Fas mRNA was used in this study. All siRNA duplexes (scrambled negative siRNA, Fam-labeled non-targeting siRNA, GAPDH-siRNA, and three siRNAs targeting rat Fas gene) were designed and synthesized by Ribio Corporation (Guangzhou, China). Seven groups were set to determine the optimal transfection condition and select effective Fas siRNA sequence. Cells transfected only with Lipofectamine TM 2000 was as a blank control, transfected with scrambled negative siRNA as a negative control, transfected with GAPDH-siRNA as a positive control, and transfected with three Fas siRNAs (Fas siRNA1: 5 0 -AGGAAACACUAUUCUGAUAdTdT-3 0 , Fas siRNA2: 5 0 -ACCAAAUGCAAGAAACAAAdTdT-3 0 , Fas siRNA3: 5 0 -CGGAAAGCAAGAUCGAUGAdTdT-3 0 ), respectively, to select effective Fas siRNA sequence. Fam-labeled nontargeting siRNA was used to determine the transfection rate by fluorescence microscopy and FCM with blue light excitation at 480 nm and emission at 520 nm. The effective Fas siRNA sequence targeting rat Fas gene was determined by RT-PCR and western blot. Briefly, the transfection was carried out according to the manufacturer's instructions. The primary cultured NP cells were transferred to 6-well plates at a density of 3 Â 10 5 cells/well in DMEM/F-12 with 10% FBS without antibiotics the day before transfection procedure. The medium was refreshed by 1.5 ml of OPTI-MEM (Gibco) per well 1 h before transfection. The NP cells were transfected with siRNA at a final concentration of 100 nM using Lipofectamine TM 2000 according to the manufacturer's instructions. After 8 h, the solution was replaced with complete culture medium to reduce cytotoxicity without reducing transfection efficiency.
Fas siRNA-transfected NP cells treated with FasL
The group of NP cells transfected only with Lipofectamine TM 2000 was set as the blank control group, one group of NP cells transfected with Fas siRNA was as the transfected control group, and four Fas siRNA-transfected groups treated with FasL of different concentrations were as the treated groups. Forty-eight hours after transfection, cells were refreshed with DMEM/F-12 containing 1% FBS without antibiotics, and cultured for another 12 h. Then, the cells of Fas siRNA-transfected groups were treated with 5, 10, 20, or 50 ng/ml FasL in refreshed DMEM/F-12 containing 1% FBS without antibiotics for further 24 h. Then, the cells were collected to detect the apoptosis incidence and the expression of Fas was also evaluated by RT-PCR and western blotting.
Statistical analysis
All data were presented as mean + SD. Statistical difference among the groups was analyzed by one-way ANOVA with LSD post hoc multiple comparisons analysis. Software SPSS 11.0 was used for statistics analysis. Significance was accepted at P , 0.05. All experiments were performed at least three times to insure consistency.
Results
Normal NP cells treated with FasL After normal rat NP cells were stimulated by different concentrations of recombinant rat FasL in DMEM/F-12 containing 1% FBS for 24 h, the morphology was Effect of Fas ligand on intervertebral disc cells observed by phase-contrast microscopy; plasma membrane blebbing (yellow arrows) was found in apoptotic NP cells under phase-contrast microscope [ Fig. 1(A,C) ].
The expression of Fas gene was detected by RT-PCR. The results of RT-PCR demonstrated that the expression of the Fas mRNA was significantly up-regulated by recombinant FasL [ Fig. 2(A,B) ].
Compared with the control group, the expression of Fas mRNA was increased by 2.1-2.6 folds when NP cells were stimulated by different concentrations of FasL [ Fig. 2(A,B) ] (P , 0.01). The level of Fas protein was determined by western blotting. The Fas protein was also markedly enhanced by FasL [ Fig. 2(C,E) ] as determined by western blotting. 
Effect of Fas ligand on intervertebral disc cells
The cell apoptosis incidence was evaluated by FCM. It was found that the apoptosis incidence of NP cells was elevated by FasL in a dose-dependent manner (Fig. 3) . In the normal groups, the apoptosis incidence was about 4.3 + 0.3%, 7.8 + 0.6%, 13.5 + 1.1%, and 21.5 + 3.7%, after cells were treated by 5, 10, 20, and 50 ng/ml of FasL for 24 h, respectively. It was about 1.2, 2.2, 3.9, and 6.2 folds higher than those of the control group [ Fig. 3(B) ]. These results suggested that FasL enhanced apoptosis incidence of NP cells by up-regulating Fas expression.
Efficacy of Fas siRNA
Lots of green dots were seen in NP cells under fluorescence microscope 16 h after Fam-labeled siRNA transfection, compared with the NP cells transfected with scrambled negative siRNA (no Fam-labeled) [ Fig. 4(A,B) ]. The transfection concentration of siRNA Effect of Fas ligand on intervertebral disc cells used in the current experiment was 100 nM. The transfection rate was $94% determined by FCM [ Fig. 4(C) ]. The most effective Fas siRNA sequence selected and used in the subsequent study was 5 0 -ACCAAAUGCAA-GAAACAAA-3 0 (Fas siRNA2). Suppression of targeted mRNA was established 24 h after transfection and was maintained for up to 72 h [ Fig. 5(A,B) ]. Forty-eight hours after transfection, Fas gene silencing resulted in a maximum reduction of Fas mRNA expression by to 80% [ Fig. 5(A,B) ], and the amount of Fas protein was reduced by 74% compared with that of the blank control [ Fig. 5(C,D) ].
Fas siRNA-transfected NP cells treated with FasL When Fas siRNA-transfected rat NP cells were stimulated by different concentrations of recombinant rat FasL in DMEM/F-12 containing 1% FBS for 24 h, the expression of Fas and apoptosis incidence of the cells were detected. Plasma membrane blebbing was also found in apoptotic NP cells by phase-contrast microscopy [ Fig. 1(B,D) ].
Eighty-four hours after Fas siRNA transfection, there was no difference of Fas gene expression among the Fas siRNA-transfected groups, no matter the cells were stimulated with or without FasL (data not shown). However, the expression of Fas protein decreased to 28-57% in the transfected groups when cells were stimulated by different concentrations of FasL compared with that of the blank control group [ Fig. 2(D,E) ].
In the Fas siRNA-transfected groups, the apoptosis incidence of FasL-treated groups was about 4.3 + 0.6%, 6.0 + 0.4%, 6.8 + 1.3%, and 9.1 + 0.6%, when cells were treated by 5, 10, 20, and 50 ng/ml FasL for 24 h, respectively. It was about 1.2, 1.6, 1.9, and 2.6 folds higher than that of the blank control group (Fig. 6) . Compared with the normal group [ Fig. 3(B) ], the increase in tendency of apoptosis incidence following addition of FasL was slight in the Fas siRNA-transfected groups [ Fig. 6(B) ]. When cells were treated with 20 or 50 ng/ml FasL, significantly lower apoptosis incidence was found in the Fas siRNA-transfected groups compared with the normal Effect of Fas ligand on intervertebral disc cells groups (6.8 + 1.3% vs 13.5 + 1.1% if cells were treated with 20 ng/ml FasL, 9.1 + 0.6% vs 21.5 + 3.7% if cells were treated with 50 ng/ml FasL, P , 0.001) (Fig. 7) . The apoptosis incidence was also lower in the Fas siRNA-transfected group than that in the normal group when cells were treated with 10 ng/ ml FasL (6.0 + 0.4% vs 7.8 + 0.6%, P . 0.05), although there was no statistical difference (Fig. 7) .
Discussion
FasL is a type II membrane protein that belongs to the TNF family, and on binding to its receptor, Fas acts as a cell-death-triggering ligand to induce apoptosis [7, 8] . But, nowadays the role of FasL is still under debate [12] . Some researches have demonstrated that FasL may also possess an inflammatory function [14, 15] . Recent studies have revealed that the role of FasL may also be different on IVD [5, [17] [18] [19] . In degenerative disc tissues, the demonstrated significantly lower apoptosis incidence compared with those of cells in the normal groups, respectively (6.8 + 1.3% vs 13.5 + 1.1% when cells treated with 20 ng/ml FasL, 9.1 + 0.6% vs 21.5 + 3.7% when cells treated with 50 ng/ml FasL, **P , 0.001). The apoptosis incidence was also lower in the transfected group than that in the normal group when cells were treated with 10 ng/ml FasL (6.0 + 0.4% vs 7.8 + 0.6%, P . 0.05).
Effect of Fas ligand on intervertebral disc cells
increased IVD cell apoptosis is correlated with the higher expression of FasL and Fas [4 -6] . Since the inflammatory cytokines can significantly enhance the Fas expression and led to cell apoptosis [21] , we wonder whether FasL has the same effect on IVD cells. So, we first investigated the expression of Fas in NP cells when they were stimulated with rat recombinant FasL in vitro.
In this study, for the first time, we evaluated the effects of different concentration of recombinant FasL on rat NP cells. The results suggested that the FasL could markedly stimulate NP cells to express Fas both in mRNA and in protein level. It was consistent with previous study that the expression of Fas on IVD cells could be up-regulated by many factors such as trauma [17] , serum deprivation [6] , etc. Meanwhile, the apoptotic incidence of NP cells was markedly increased in a FasL dose-dependent manner. These results confirmed that FasL played double roles in rat NP cells, up-regulating Fas expression and provocating Fas/FasL pathway to cause cell apoptosis.
The current experiment results showed that FasL up-regulated the expression of Fas and increased the cells' apoptosis incidence in the dose-dependent manner in cultured rat NP cells. It suggested that activation of Fas/FasL-induced apoptosis might need sufficient FasL, and that FasL might have proapoptotic and proinflammatory function on IVD cells. First, FasL acts as an apoptosis-ligand which can bind with Fas to activate the process of apoptosis. Second, FasL acts as an apoptosis-inducer that can elevate the Fas expression if there are not many Fas-positive cells, then as an apoptosis-ligand that induce the cell apoptosis. So that the cell apoptosis incidence was in a FasL dosedependent manner is reasonable. In disc annular puncture rabbit model, Wang et al. [17] . have suggested that the immunological privilege of NP is maintained by FasL and the physiological barrier together. When the physiological barrier was damaged, the role of FasL was changed, and FasL was coexpressed with Fas to induce apoptosis of disc cells [17] . Combining with our results, these may provide a new insight into the function of FasL in the process of IDD. Interestingly, the up-regulation of Fas expression and higher incidence of apoptosis of NP cells could be inhibited by Fas siRNA.
RNA interference is a potent and specific method for controlling gene expression [22, 23] and is a promising new approach for the biological treatment of human disease [24, 25] . Song et al. [26] have already demonstrated that intravenous siRNA injection targeting Fas could inhibit Fas expression on mouse hepatocytes in vivo and protect hepatocytes from Fas-mediated apoptosis. However, the application of RNAi technology in the research on IVD was emerged until 2006. Kakutani et al. [27] made a first report of the efficacy of RNAi in cultured NP cells in vitro, using siRNA duplexes targeting Firefly luciferase and green fluorescent protein. Tsai et al. [28, 29] demonstrated the function of TonEBP/ OREBP in rat NP cells with RNAi. Zeng et al. [30] confirmed that HIF-1a was a regulator of galectin-3 expression in the IVD by using siRNA and pharmacological inhibitors. Just recently, Suzuki et al. [31] reported a method of long-term down-regulation FasL gene by unmodified siRNA in SD rat disc in vivo. The expression of endogenous FasL gene was inhibited by siRNA markedly, and the inhibitory effect of siRNA was maintained for at least 24 weeks. This application of RNAi might be promising as a local therapy for disc degeneration and associated disorders by down-regulating some of the genes that are harmful for the normal physiology of the disc and may cause disc degeneration [31, 32] . But until now, there was no result about RNAi technique used in the apoptosis of IVD cells.
In this study, we first used this technique to prevent NP cells from apoptosis. The transfection rate was $94% determined by FCM. Fas gene silencing resulted in a maximum reduction of Fas mRNA expression by $80% compared with the control 48 h after transfection. The results were similar to that of Klatt et al. [33] . But, the inhibitory effect of siRNA was lower than that of Kakutani et al. [27] . The reason for the difference might be that the gene silenced by Kakutani et al. was exogenous reporter gene not endogenous gene.
Our results showed that FasL-induced apoptosis of rat NP cells was sharply reduced by Fas siRNA. This strongly suggested that suppression of excessive apoptosis of IVD cells by RNAi was feasible. It is believed that Fas/FasL system-mediated apoptosis played a pivotal role in IVD cells apoptosis [2, 3, 5, 6] . Furthermore, some authors have suggested that suppression of apoptosis may be a potential strategy for retarding IDD [2, 3, 6] . If this is true, RNA interference is a potent and promising new approach for the biological treatment of human IDD disease [32] . Notably, Fas siRNA could not suppress the Fas expression and apoptosis completely in our experiment. There may be three reasons: first, it may be due to the efficiency of RNA interference technology [24] [25] [26] 33] . Second, the Fas siRNA sequence we used may not be the best one. Third, there may be other apoptosis pathway or crosslink with other pathway existed in IVD cells [2, 7] . Although we were successful in preventing Effect of Fas ligand on intervertebral disc cells cultured rat NP cells from apoptosis by RNAi, for scientific research purposes and a therapeutic strategy, a much longer inhibition effect may be required. Much longer inhibition by vector-based RNAi technology [34] for IVDs needs to be investigated, so that the disadvantages of the short duration of effectiveness in RNAi can be overcome. Furthermore, whether the apoptosis of NP cells can be prevented by RNAi in vivo should also be investigated.
In summary, our results demonstrated that FasL might play double roles in rat NP cells apoptosis, and apoptosis of NP cells could be partially inhibited by RNA interference. RNAi may be a promising option for the development of novel therapeutic strategies for IDD.
